HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population

Multiple Sclerosis

Volumn 10, Issue 4, 2004, Pages 381-386

  Al Shammri, S ^a   Nelson, R F ^b   Al Muzairi, I ^c   Akanji, Abayomi O ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF OTTAWA   (Canada)

^c IBN SINA HOSPITAL   (Kuwait)

Author keywords

Arabs; Genetic susceptibility; HLA typing; Kuwait; Multiple sclerosis

Indexed keywords

COMPLEMENT; HLA A ANTIGEN; HLA A10 ANTIGEN; HLA A19 ANTIGEN; HLA A33 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B5 ANTIGEN; HLA C ANTIGEN; HLA CW4 ANTIGEN; HLA DQ ANTIGEN; HLA DQ5 ANTIGEN; HLA DQ6 ANTIGEN; HLA DQ7 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; HLA DR6 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARAB; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FREQUENCY ANALYSIS; GENDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PHENOTYPE; POPULATION RESEARCH; RATING SCALE; RELAPSE; REMISSION; SEX DIFFERENCE; STANDARD; TISSUE TYPING;

ADOLESCENT; ADULT; AGE OF ONSET; ARABS; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KUWAIT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX CHARACTERISTICS;

EID: 4344683444     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1065oa     Document Type: Article

References (23)

1. Silberberg D. Editorial: millennium reflections. Mult Scler 2001; 7: 1-3.
2. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994; 54: 1-17.
3. Hillert J, Olerup O. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, and DW2 haplotype. Neurology 1993; 43: 163-68.
4. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA. Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 1995; 58: 183-90.
5. Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 1988; 38: 1749- 53.
6. Marrosu MG, Muntoni F, Murru MR, Costa G, Pischedda MP, Pirastu M et al. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 *0302 alleles. Neurology 1992; 42: 883-86.
7. Al-Din ASN, Khogali M, Poser CM, Al-Nassar KE, Shakir R, Hussain J et al. Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 1990; 100: 137-41.
8. Kurdi A, Ayesh I, Abdallat A, Maayata U. Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans. Lancet 1977; 1: 1123-25.
9. Amirzargar A, Mytilineos J, Yousefipour A, Farjadian Sh, Scherer S, Opelz G et al. HLA Class 11 (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur J Immunogenet 1998; 25: 297-301.
10. Kalanie H, Kamgooyan M, Sadeghian H, Kalanie AR. Histo-compatibility antigen (HLA) associations with multiple sclerosis in Iran. Mult Scler 2000; 6: 317-19.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
12. Mackintosh P. HLA typing. In Thomson RD ed. Technique in clinical immunology. Oxford: Blackwell Scientific Publication, 1981: 203-21.
13. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-39.
14. Odinak MM, Bisaga GN, Kalinina NM, Akimov SB, Semilutskaia IB. 2000. Multiple sclerosis in Northern-West region of Russia: result of HLA-typing. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 2000; 100: 40-44.
15. Boiko AN, Gusev EI Sudomoina MA, Alekseenkov AD, Kulakova OG, Bikova OV et al. Association and linkage of juvenile MS with HLA-DR2 (15) in Russians. Neurology 2002; 58: 658-60.
16. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994; 36: S15-S17.
17. Perini P, Tagliaferri C, Belloni M, Biasi G, Gallo P. The HLA-DR13 haplotype is associated with benign' multiple sclerosis in northeast Italy. Neurology 2001; 57: 158-59.
18. White AG, Leheny W, Kuchipudi P, Varghese M. histocompatibility antigens in Omanis: comparison with other Gulf populations and implications for disease association. Ann Saudi Med 1999; 19: 193-96.
19. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M. HLA-DR and DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997; 55: 59-65.
20. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E et al. Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003; 72: 710-16.
21. Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C et al. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. J Neurol 2003; 250: 1099-106.
22. Klein J, Sato A. The HLA system. N Engl J Med 2000; 343: 782-86.
23. Herrera BM, Ebers GC. Progress in deciphering the genetics of multiple sclerosis. Curr Opin Neurol 2003; 16: 253-58.